Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (961-970 of 1,467) with videos related to

Pageof 147
Sort By:
Psychiatric Genetics|April 28, 2010
Using trajectory analyses to refine phenotype for genetic association: conduct problems and the serotonin transporter (5HTTLPR)Joseph T Sakai, Jason D Boardman, Heather L Gelhorn, et al.
Arthritis Research & Therapy|April 19, 2015
Regulatory T cell-deficient scurfy mice develop systemic autoimmune features resembling lupus-like diseaseEva N Hadaschik, Xiaoying Wei, Harald Leiss, et al.
Annals of the Rheumatic Diseases|March 19, 2011
Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trialVibeke Strand, Josef S Smolen, Ronald F van Vollenhoven, et al.
Annals of the Rheumatic Diseases|December 15, 2015
Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritisSofia Ramiro, Josef S Smolen, Robert Landewé, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 6, 2004
Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formationBirgit Görtz, Silvia Hayer, Kurt Redlich, et al.
Lancet (London, England)|January 6, 2000
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study GroupR Maini, E W St Clair, F Breedveld, et al.
The Journal of Clinical Investigation|November 20, 2002
Osteoclasts are essential for TNF-alpha-mediated joint destructionKurt Redlich, Silvia Hayer, Romeo Ricci, et al.
Annals of the Rheumatic Diseases|June 23, 2017
A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritisJosef S Smolen, Stanley B Cohen, Hans-Peter Tony, et al.
Nature Medicine|March 31, 2009
Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosisNikolaus B Binder, Birgit Niederreiter, Oskar Hoffmann, et al.
Annals of the Rheumatic Diseases|September 4, 2008
Patient perspective of hand osteoarthritis in relation to concepts covered by instruments measuring functioning: a qualitative European multicentre studyT Stamm, F van der Giesen, C Thorstensson, et al.
Pageof 147

Showing results (961-970 of 1,467) with videos related to

Sort By:
Pageof 147
Psychiatric Genetics|April 28, 2010
Using trajectory analyses to refine phenotype for genetic association: conduct problems and the serotonin transporter (5HTTLPR)Joseph T Sakai, Jason D Boardman, Heather L Gelhorn, et al.
Arthritis Research & Therapy|April 19, 2015
Regulatory T cell-deficient scurfy mice develop systemic autoimmune features resembling lupus-like diseaseEva N Hadaschik, Xiaoying Wei, Harald Leiss, et al.
Annals of the Rheumatic Diseases|March 19, 2011
Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trialVibeke Strand, Josef S Smolen, Ronald F van Vollenhoven, et al.
Annals of the Rheumatic Diseases|December 15, 2015
Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritisSofia Ramiro, Josef S Smolen, Robert Landewé, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 6, 2004
Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formationBirgit Görtz, Silvia Hayer, Kurt Redlich, et al.
Lancet (London, England)|January 6, 2000
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study GroupR Maini, E W St Clair, F Breedveld, et al.
The Journal of Clinical Investigation|November 20, 2002
Osteoclasts are essential for TNF-alpha-mediated joint destructionKurt Redlich, Silvia Hayer, Romeo Ricci, et al.
Annals of the Rheumatic Diseases|June 23, 2017
A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritisJosef S Smolen, Stanley B Cohen, Hans-Peter Tony, et al.
Nature Medicine|March 31, 2009
Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosisNikolaus B Binder, Birgit Niederreiter, Oskar Hoffmann, et al.
Annals of the Rheumatic Diseases|September 4, 2008
Patient perspective of hand osteoarthritis in relation to concepts covered by instruments measuring functioning: a qualitative European multicentre studyT Stamm, F van der Giesen, C Thorstensson, et al.
Pageof 147